Skip to content
MondayNightIBD Better Days Ahead? Opportunities to Improve Care for Patients with IBD: A Focus on New and Emerging Therapies Evaluation (ID: i802a-5)
*
1.
What is your degree?
(Required.)
MD/DO
NP
PA
Pharmacist
Nurse
Other (please specify)
*
2.
What is your specialty?
(Required.)
Gastroenterology
Surgery
Dietetics
Other Specialist
Internal Medicine
Family Practice
Other (please specify)
*
3.
Please select the option that best describes your setting.
(Required.)
Academic medical center
Community medical center
Other (please specify)
*
4.
How many years have you been in practice?
(Required.)
<1
1-10
11-20
>21
*
5.
How many patients with IBD do you manage monthly?
(Required.)
1 to 6
6 to 10
10 to 20
21+
I am not directly involved in patient care
*
6.
After participating in this activity, how confident are you in the management of patients with UC in your practice?
(Required.)
Very confident
Confident
Neutral
Little confidence
No confidence
*
7.
Which new strategies/skills/information will you apply to your area of practice? Please select all that apply.
(Required.)
Be better able to manage patients with UC through use of tools to monitor disease activity
Be better able to utilize evidence-based strategies to formulate optimal treatment regimens
Be better able to position therapies based on individual patient characteristics
Other (please explain)
*
8.
How committed are you to making changes in your practice based on your participation in this activity?
(Required.)
Very committed
Committed
Neutral
Not committed
I do not plan to make changes
If not committed or do not plan to make changes, please indicate reason
*
9.
What barriers do you see to making changes in your practice? Please select all that apply.
(Required.)
Lack of knowledge regarding evidence-based strategies
Lack of convincing evidence to warrant change
Lack of time/resources to consider change
Insurance, reimbursement, or legal issues
Conflicting guidelines and/or evidence
Patient compliance and/or patient resource barriers
Other (please specify)
*
10.
Please rate your level of agreement by checking the appropriate rating.
Strongly agree, Agree, Neutral, Disagree, Strongly disagree
After participating in today’s activity, I am now better able to:
(Required.)
Strongly agree
Agree
Neutral
Disagree
Strongly disagree
Apply safety and efficacy data from clinical trials of new and emerging agents to achieve an individualized, patient-centered approach to IBD management
Strongly agree
Agree
Neutral
Disagree
Strongly disagree
Analyze potential approaches for positioning new and emerging therapies for UC
Strongly agree
Agree
Neutral
Disagree
Strongly disagree
Evaluate complex clinical situations in which patients with IBD may benefit from management strategies, including novel therapies
Strongly agree
Agree
Neutral
Disagree
Strongly disagree
*
11.
Please rate your level of agreement by checking the appropriate rating.
(Required.)
Strongly agree
Agree
Neutral
Disagree
Strongly disagree
Faculty for this activity was effective
Strongly agree
Agree
Neutral
Disagree
Strongly disagree
Content was scientifically rigorous and evidence based
Strongly agree
Agree
Neutral
Disagree
Strongly disagree
Avoided commercial bias or influence
Strongly agree
Agree
Neutral
Disagree
Strongly disagree
12.
If you indicated that you perceived commercial bias or influence, please describe:
13.
As a result of your participation in this activity, what is the one change you are most likely to implement in your practice?
14.
Please list any clinical issues/problems within your scope of practice you would like to see addressed in future educational activities: